Integer appoints Michael Coyle to board of directors

Integer Holdings Corporation (NYSE: ITGR) appointed Michael Coyle to its board of directors, the medical device contract development and manufacturing organization announced.

Coyle brings more than 40 years of medical device industry leadership experience to Integer's board. He will serve on the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee.

Coyle most recently served as president and CEO of iRhythm Technologies, a digital healthcare company. He previously held the position of executive vice president and group president of Medtronic's cardio and vascular group and had leadership roles at St. Jude Medical and Eli Lilly earlier in his career.

He currently serves as a director on the Haemonetics Corporation and BaroPace boards and previously held board positions at VNUS Medical Technologies, Inc. and Volcano Corporation.

Coyle earned a master's degree in business administration from the Wharton School of Business, University of Pennsylvania, and a bachelor's degree from Case Western Reserve University. He holds six U.S. patents related to cardiovascular medical device products and technologies.

"Integer's Board regularly evaluates its composition to ensure it encompasses the appropriate skills, background and perspectives necessary to drive growth for Integer's shareholders," said Pamela Bailey, Integer Board Chair.

Joseph Dziedzic, Integer president and CEO, said the company looks forward to working with Coyle as it executes its strategy.

Integer is a medical device contract development and manufacturing organization serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets, according to the company's press release.

You May Also Be Interested In